Cargando…
Optimization of Clonazepam Therapy Adjusted to Patient’s CYP3A Status and NAT2 Genotype
BACKGROUND: The shortcomings of clonazepam therapy include tolerance, withdrawal symptoms, and adverse effects such as drowsiness, dizziness, and confusion leading to increased risk of falls. Inter-individual variability in the incidence of adverse events in patients partly originates from the diffe...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203763/ https://www.ncbi.nlm.nih.gov/pubmed/27639091 http://dx.doi.org/10.1093/ijnp/pyw083 |